|
Title
|
Published
|
Price
|
By
Timely Data resources
The Schizophrenia Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatment. Dosing an...
|
February
2013
|
$
950
|
By
Wildwood Ventures Ltd
This report provides understanding and access to the schizophrenia partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in schizophrenia partnering deals Top schizophrenia deals by val...
|
May
2012
|
$
995
|
By
Global Markets Direct
Schizophrenia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Schizophrenia - Pipeline Review, H1 2012', provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therapeutic developmen
|
February
2012
|
$
500
|
By
GlobalData
GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2011" provides data on the Schizophrenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Schizophren
|
October
2011
|
$
1000
|
By
Global Markets Direct
Global Markets Direct’s, 'Schizophrenia - Pipeline Review, H2 2011', provides an overview of the Schizophrenia therapeutic pipeline. This...
|
September
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therap...
|
February
2011
|
$
500
|
By
GlobalData
GlobalData's clinical trial report, provides data on the Schizophrenia clinical trial scenario. This report provides in-depth information and data re...
|
January
2011
|
$
1000
|
By
Global Markets Direct
Global Markets Direct’s, “Schizophrenia Pipeline Review, Q4 2010”, provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therapeu...
|
December
2010
|
$
500
|
By
Life Science Analytics
Life Science Analytics', contains detailed information on the schizophrenia drug pipeline. This report provides insight into the pipeline status of schizoph...
|
July
2010
|
$
1495
|
By
Espicom Limited
This chapter of CNS Drug Discoveries focuses on the schizophrenia market.
|
August
2008
|
$
1040
|